Absci Corporation to Present at J.P. Morgan Healthcare Conference
Absci Corporation (NASDAQ: ABSI), a clinical-stage biopharmaceutical company, announced its participation in the 44th Annual J.P. Morgan Healthcare Conference. The company utilizes generative AI and synthetic biology to develop therapeutic candidates and will present its discovery platform at the event.
On Dec 17, 2025, H.C. Wainwright established a price target of $8 USD for the company. At the time of the target setting, ABSI shares were priced at $3.44. As of Dec 18, 2025, the stock is trading at $3.39, representing a 4.5% decrease of $0.16 from the previous session.
The company has a market capitalization of approximately $510.4 million. Trading volume on the NASDAQ exchange was 1,986,998 shares. Over the past 52 weeks, the stock has fluctuated between a low of $2.01 and a high of $6.33, with a daily range between $3.38 and $3.64.
Additional information regarding the company mission and investor profile is available through these resources:
Absci Corporation (ABSI) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.